Skip to content

Peter Rhode

Executive Officer at HCW Biologics.

Earliest Form D on file: Jun 2026

Filed Jun 8, 2026

HCW Biologics

Fusion protein drugs for inflammation-driven disease

Biotech, Miramar FL

Named, Executive Officer.

$4M

sold of $4M offered

Form D

Network

At HCW Biologics

6 people